Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Nöckel, Jessica ^a,b   van den Engel, Natasja K ^b   Winter, Hauke ^b   Hatz, Rudolf A ^b   Zimmermann, Wolfgang ^a   Kammerer, Robert ^a,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CELL ADHESION MOLECULE; EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUCIN; UVOMORULIN; VIRUS T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CARCINOGENICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXPERIMENTAL NEOPLASM; FEMALE; FLOW CYTOMETRY; HAPLOTYPE; IMMUNOGENICITY; IN VITRO STUDY; INVASIVE CARCINOMA; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; TRANSGENIC MOUSE; TUMOR REJECTION; VACCINATION; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; C57BL MOUSE; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHENOTYPE; STOMACH TUMOR; TRANSGENE; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CARCINOEMBRYONIC ANTIGEN; CELL LINE, TUMOR; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; STOMACH NEOPLASMS; TRANSGENES;

EID: 33645464303     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-57     Document Type: Article

References (47)

1. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM: Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 2005, 241:27-39.
2. Banchereau J, Palucka AK: Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005, 5:296-306.
3. Overwijk WW: Breaking tolerance in cancer immunotherapy: time to ACT. Curr Opin Immunol 2005, 17:187-194.
4. Homma S, Matai K, Irie M, Ohno T, Kufe D, Toda G: Immunotherapy using fusions of autologous dendritic cells and tumor cells showed effective clinical response in a patient with advanced gastric carcinoma. J Gastroenterol 2003, 38:989-994.
5. Kono K, Takahashi A, Ichihara, F, Amemiya H, Iizuka H, Fujii H, Sekikawa T, Matsumoto Y. Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial. Clin Cancer Res 2002, 8:1767-1771.
6. Yanai H, Kuroiwa Y, Shimizu N, Matsubara Y, Okamoto T, Hirano A, Nakamura Y, Okita K, Sekine T: The pilot experience of immunotherapy-combined photodynamic therapy for advanced gastric cancer in elderly patients. Int J Gastrointest Cancer 2002, 32:139-142.
7. Matsumoto S, Saito H, Tsujitani S, Ikeguchi M: Allogeneic gastric cancer cell-dendritic cell hybrids induce tumor antigen (carcinoembryonic antigen) specific CD8+ T cells. Cancer Immunol Immunother 2006, 55:131-139.
8. Niiya F, Nishizaka S, Matsunaga K, Koufuji K, Mori M, Katai H, Yamana H, Itoh K. Expression of SART3 tumor-rejection antigen in gastric cancers. Jpn J Cancer Res 2000, 91:337-342.
9. Sasada T, Takedatsu H, Azuma K, Koga M, Maeda Y, Shichijo S, Shoumura H, Hirai T, Takabayashi A, Itoh K: Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte (CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric cancer patients. Cancer Res 2004, 64:2882-2888.
10. Inoue H, Mori M, Honda M, Li J, Shibuta K, Mimori K, Ueo H, Akiyoshi T: The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma. Gastroenterology 1995, 109:1522-1525.
11. Zhang HK, Zhang QM, Zhao TH, Li YY, Yi YF: Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. World J Gastroenterol 2004, 10:3044-3047.
12. Pritchard DM, Przemeck SM: Review article: How useful are the rodent animal models of gastric adenocarcinoma? Aliment Pharmacol Ther 2004, 19:841-859.
13. Thompson J, Epting T, Schwarzkopf G, Singhofen A, Eades-Perner AM, van Der PH, Zimmermann W: A transgenic mouse line that develops early-onset invasive gastric carcinoma provides a model for carcinoembryonic antigen-targeted tumor therapy. Int J Cancer 2000, 86:863-869.
14. Eades-Perner AM, van Der PH, Hirth A, Thompson J, Neumaier M, von Kleist S, Zimmermann W: Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern. Cancer Res 1994, 54:4169-4176.
15. Chung JK, Choi CW, Lee MC, Chung HK, Kim NK, Choi KW, Koh CS: Radioimmunoscintigraphy of advanced gastrointestinal carcinomas employing I-131 labeled CEA-79 monoclonal antibody. Ann Nucl Med 1993, 7:65-70.
16. Tamai M, Tanimura H, Yamaue H, Iwahashi M, Tsunoda T, Tani M, Noguchi K, Mizobata S, Hotta T, Arii K,.: Clinical significance of quantitative analysis of carcinoembryonic antigen assessed by flow cytometry in fresh human gastric cancer cells. Cancer Lett 1995, 90:111-117.
17. Horig H, Medina FA, Conkright WA, Kaufman HL: Strategies for cancer therapy using carcinoembryonic antigen vaccines. Expert Rev Mol Med 2000, 2000:1-24.
18. Sarobe P, Huarte E, Lasarte J.J. Borras-Cuesta F. Carcinoembryonic antigen as a target to induce anti-tumor immune responses. Curr Cancer Drug Targets 2004, 4:443-454.
19. Babatz J, Rollig C, Lobel B, Folprecht G, Haack M, Gunther H, Kohne CH, Ehninger G, Schmitz M, Bornhauser M: Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells. Cancer Immunol Immunother 2006, 55:268-276.
20. Mylin LM, Bonneau RH, Lippolis JD, Tevethia SS: Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J Virol 1995, 69:6665-6677.
21. Mylin LM, Schell TD, Roberts D, Epler M, Boesteanu A, Collins EJ, Frelinger JA, Joyce S, Tevethia SS. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. J Virol 2000, 74:6922-6934.
22. Schmitz J, Reali E, Hodge JW, Patel A, Davis G, Schlom J, Greiner JW: Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice. Cancer Res 2002, 62:5058-5064.
23. Kammerer R, Stober D, Riedl P, Oehninger C, Schirmbeck R, Reimann J: Noncovalent association with stress protein facilitates cross-priming of CD8+ T cells to tumor cell antigens by dendritic cells. J Immunol 2002, 168:108-117.
24. Kuprina NI, Baranov VN, Yazova AK, Rudinskaya TD, Escribano M, Cordier J, Gleiberman AS, Goussev AI: The antigen of bile canaliculi of the mouse hepatocyte: identification and ultrastructural localization. Histochemistry 1990, 94:179-186.
25. Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM: Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 1997, 57:3325-3330.
26. Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, Pestell RG, Di Vizio D, Loda M, Lisanti MR Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem 2005, 280:25134-25145.
27. Xiao D, Zeng Y, Choi S, Lew KL, Nelson JB, Singh SV: Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax. Clin Cancer Res 2005, 11:2670-2679.
28. Qian SS, Gao J, Wang JX, Liu Y, Dong HY. [Establishment of a mouse forestomach carcinoma cell line (MFC) with spontaneous hematogenous metastasis and preliminary study of its biological characteristics]. Zhonghua Zhong Liu Za Zhi 1987, 9:261-264.
29. Kinugasa T, Kuroki M, Takeo H, Matsuo Y, Ohshima K, Yamashita Y, Shirakusa T, Matsuoka Y: Expression of four CEA family antigens (CEA, NCA, BGP and CGM2) in normal and cancerous gastric epithelial cells: up-regulation of BGP and CGM2 in carcinomas. Int J Cancer 1998, 76:148-153.
30. Zebhauser R, Kammerer R, Eisenried A, McLellan A, Moore T, Zimmermann W: Identification of a novel group of evolutionarily conserved members within the rapidly diverging murine Cea family. Genomics 2005, 86:566-580.
31. Nakamura E, Sugihara H, Bamba M, Hattori T: Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. J Pathol 2005, 205:349-358.
32. Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O: The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 2004, 23:5748-5758.
33. Eidelman FJ, Fuks A, DeMarte L, Taheri M, Stanners CP: Human carcinoembryonic antigen, an intercellular adhesion molecule, blocks fusion and differentiation of rat myoblasts. J Cell Biol 1993, 123:467-475.
34. Ordonez C, Screaton RA, Ilantzis C, Stanners CP: Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res 2000, 60:3419-3424.
35. Ilantzis C, DeMarte L, Screaton RA, Stanners CP: Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia 2002, 4:151-163.
36. Luo W, Tapolsky M, Earley K, Wood CG, Wilson DR, Logothetis CJ, Lin SH: Tumor-suppressive activity of CD66a in prostate cancer. Cancer Gene Ther 1999, 6:313-321.
37. Turbide C, Kunath T, Daniels E, Beauchemin N: Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth. Cancer Res 1997, 57:2781-2788.
38. Laack E, Nikbakht H, Peters A, Kugler C, Jasiewicz Y, Edler L, Brummer J, Schumacher U, Hossfeld DK: Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance. J Clin Oncol 2002, 20:4279-4284.
39. Sienel W, Dango S, Woelfle U, Morresi-Hauf A, Wagener C, Brummer J, Mutschler W, Passlick B, Pantel K: Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 promotes progression of non-small cell lung cancer. Clin Cancer Res 2003, 9:2260-2266.
40. Thies A, Moll I, Berger J, Wagener C, Brummer J, Schulze HJ, Brunner G, Schumacher U: CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J Clin Oncol 2002, 20:2530-2536.
41. Schell TD, Mylin LM, Georgoff I, Teresky AK, Levine AJ, Tevethia SS: Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice. J Virol 1999, 73:5981-5993.
42. Soldevila G, Geiger T, Flavell RA: Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen. J Immunol 1995, 155:5590-5600.
43. Zheng X, Gao, JX, Zhang H, Geiger TL, Liu Y, Zheng P: Clonall deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens overexpressed in solid tumors. J Immunol 2002, 169:4761-4769.
44. Hance KW, Zeytin HE, Greiner JW: Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines. Mutat Res 2005, 576:132-154.
45. Saha A, Baral RN, Chatterjee SK, Mohanty K, Pal S, Foon KA, Primus FJ, Krieg AM, Weiner GJ, Bhattacharya-Chatterjee M: CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice. Cancer Immunol Immunother 2005, [Epub ahead of print]: 1-13.
46. Schwegler C, Dorn-Beineke A, Nittka S, Stocking C, Neumaier M: Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice. Cancer Res 2005, 65:1925-1933.
47. Xiang R, Silletti S, Lode HN, Dolman CS, Ruehlmann JM, Niethammer AG, Pertl U, Gillies SD, Primus FJ, Reisfeld RA: Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice. Clin Cancer Res 2001, 7:856s-864s.